Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, announced the promotion of Dr. Suresh Durgam to the position of Chief Medical Officer. Dr. Suresh Durgam succeeds Dr. Andrew Satlin, who will step down as Chief Medical Officer, and will leave the Company effective October…